FASEB Conference 2014
August 11, 2014EFX Sports™ Partners With Billings Wolves Football
November 7, 2014BILLINGS, Mont.
Coupled with the recent announcement that they will be doing clinical studies on one of their products to gauge its impact for pre-diabetic individuals, All American Pharmaceutical & Natural Food Corporation (AAP) also received approval on a grant application to reduce costs for expansion, by the board of the Big Sky Economic Development Authority (EDA). AAP plans to invest $650,000 in new equipment and staffing at their location at 2375 Main Street.
As a contract manufacturer of dietary supplements, AAP is researching the impact their product, KarboLyn®, has on glucose response in normal, and pre-diabetic adults during aerobic activity.
The clinical study will be headed by Dr. Thomas Harman, a former Family Medicine Department chairman at the Mayo Clinic in Rochester, Minnesota.
AAP has applied for a $180,000 grant from Big Sky Economic Development Trust Fund, Category 1 Grant.